rs1130484

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004082.5(DCTN1):​c.2448A>G​(p.Ala816Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00893 in 1,614,236 control chromosomes in the GnomAD database, including 155 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 57 hom., cov: 32)
Exomes 𝑓: 0.0080 ( 98 hom. )

Consequence

DCTN1
NM_004082.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.97

Publications

8 publications found
Variant links:
Genes affected
DCTN1 (HGNC:2711): (dynactin subunit 1) This gene encodes the largest subunit of dynactin, a macromolecular complex consisting of 10 subunits ranging in size from 22 to 150 kD. Dynactin binds to both microtubules and cytoplasmic dynein. Dynactin is involved in a diverse array of cellular functions, including ER-to-Golgi transport, the centripetal movement of lysosomes and endosomes, spindle formation, chromosome movement, nuclear positioning, and axonogenesis. This subunit interacts with dynein intermediate chain by its domains directly binding to dynein and binds to microtubules via a highly conserved glycine-rich cytoskeleton-associated protein (CAP-Gly) domain in its N-terminus. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause distal hereditary motor neuronopathy type VIIB (HMN7B) which is also known as distal spinal and bulbar muscular atrophy (dSBMA). [provided by RefSeq, Oct 2008]
DCTN1 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • neuronopathy, distal hereditary motor, type 7B
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Perry syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • distal hereditary motor neuropathy type 7
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-74366801-T-C is Benign according to our data. Variant chr2-74366801-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.97 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0177 (2696/152342) while in subpopulation AFR AF = 0.0436 (1814/41572). AF 95% confidence interval is 0.042. There are 57 homozygotes in GnomAd4. There are 1290 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2696 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DCTN1NM_004082.5 linkc.2448A>G p.Ala816Ala synonymous_variant Exon 21 of 32 ENST00000628224.3 NP_004073.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DCTN1ENST00000628224.3 linkc.2448A>G p.Ala816Ala synonymous_variant Exon 21 of 32 5 NM_004082.5 ENSP00000487279.2

Frequencies

GnomAD3 genomes
AF:
0.0177
AC:
2687
AN:
152224
Hom.:
57
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0435
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0137
Gnomad ASJ
AF:
0.0253
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0114
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00692
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0101
AC:
2539
AN:
251492
AF XY:
0.0100
show subpopulations
Gnomad AFR exome
AF:
0.0450
Gnomad AMR exome
AF:
0.00411
Gnomad ASJ exome
AF:
0.0306
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00323
Gnomad NFE exome
AF:
0.00695
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.00801
AC:
11714
AN:
1461894
Hom.:
98
Cov.:
33
AF XY:
0.00803
AC XY:
5839
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0480
AC:
1606
AN:
33480
American (AMR)
AF:
0.00467
AC:
209
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0279
AC:
730
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0145
AC:
1250
AN:
86258
European-Finnish (FIN)
AF:
0.00344
AC:
184
AN:
53420
Middle Eastern (MID)
AF:
0.0118
AC:
68
AN:
5768
European-Non Finnish (NFE)
AF:
0.00634
AC:
7055
AN:
1112012
Other (OTH)
AF:
0.0101
AC:
609
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
882
1764
2647
3529
4411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0177
AC:
2696
AN:
152342
Hom.:
57
Cov.:
32
AF XY:
0.0173
AC XY:
1290
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0436
AC:
1814
AN:
41572
American (AMR)
AF:
0.0137
AC:
210
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
88
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0114
AC:
55
AN:
4824
European-Finnish (FIN)
AF:
0.00207
AC:
22
AN:
10626
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00692
AC:
471
AN:
68034
Other (OTH)
AF:
0.0147
AC:
31
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
138
276
413
551
689
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0130
Hom.:
17
Bravo
AF:
0.0195
Asia WGS
AF:
0.00866
AC:
30
AN:
3478
EpiCase
AF:
0.00774
EpiControl
AF:
0.00551

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 10, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Mar 17, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuronopathy, distal hereditary motor, type 7B Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Neuronopathy, distal hereditary motor, type 7B;C1862939:Amyotrophic lateral sclerosis type 1;C1868594:Perry syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Perry syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
5.4
DANN
Benign
0.47
PhyloP100
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1130484; hg19: chr2-74593928; COSMIC: COSV62621026; COSMIC: COSV62621026; API